Health System

As hospital and health systems experienced nearly 20% growth in the specialty drug market in 2018, health systems continue to establish their own specialty pharmacies or expand their existing capabilities.

A report issued this week at the 2019 American Society of Health System Pharmacists Midyear Clinical Meeting & Exposition from McKesson RxO detailed the major trends and challenges in health care ahead.

Two new best practices, a new classification, and 5 updated existing rules.

Awarded at the ASHP 2019 reception.

Takeaways from a roundtable at ASHP 2019.

Presented at the ASHP Midyear 2019.

Based upon results from a military population study presented at ASHP 2019.

The pair were recognized for contributions to the association and industry.

Results at ASHP 2019 suggest potential for administration errors without proper guidance.

RDTs can improve outcomes and reduce unnecessary antibiotic use. 

Results from a poster at ASHP 2019.

Pharmacists provide clinical training and operational skillsets.

Health systems urged to adopt antibiotic stewardship programs by March 2020. 

Biosimilar to Remicade

Patients with type 2 diabetes should keep taking their medication.

Kroger recently launched an initiative that enables hospitals and health care networks to leverage Kroger resources to provide broader access and value-based health care.

Allergan’s positive phase 3 trial results indicate a potential use for the CGRP receptor agonist.

Pharmacists can help advocate for availability and coverage.

Removing patient barriers to generic drugs.

One in 5 older adults said that they’ve taken leftover antibiotics from a previous prescription without checking in with a health care professional.

Conveniently for pharmacists and their patients, both the flu shot and Shingrix (RZV) can be administered during the same clinical visit.

Side-by-side comparisons may persuade patients to receive the vaccine.

A new study shows increases in the misuse of non-opioid medications among US adults coinciding with decreases in opioid prescribing.

Recent approval under new international Project Orbis.

What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.

Ultra-rare, potentially life-threatening genetic disease.

Hemoglobin S Polymerization inhibitor oral treatment.

Evidence-based framework is an urgent need, study says.

Ranitidine recalls, Dollar Tree warnings prompt new safety steps.

The infractions that are most likely to get your pharmacy fined-and what you can learn from them.